Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지
DOI QR코드

DOI QR Code

Early Diagnosis and Management of Chronic Obstructive Pulmonary Disease

만성 폐쇄성 폐질환의 조기 진단과 관리

  • Lee, Sei-Won (Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine) ;
  • Yoo, Jee-Hong (Department of Internal Medicine, Kyung Hee University Hospital) ;
  • Park, Myung-Jae (Department of Internal Medicine, Kyung Hee University Hospital) ;
  • Kim, Eun-Kyung (Department of Internal Medicine, CHA Bundang Medical Center, CHA University) ;
  • Yoon, Ho-Il (Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine) ;
  • Kim, Deog-Kyeom (Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul National University College of Medicine) ;
  • Lee, Chang-Hoon (Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul National University College of Medicine) ;
  • Park, Yong-Bum (Department of Internal Medicine, Kang-Dong Sacred Heart Hospital, Hallym University College of Medicine) ;
  • Park, Joo-Hun (Department of Pulmonary and Critical Care Medicine, Ajou University School of Medicine) ;
  • Hwang, Yong-Il (Department of Internal Medicine, Hallym University Sacred Heart Hospital) ;
  • Jung, Ki-Suck (Department of Internal Medicine, Hallym University Sacred Heart Hospital) ;
  • Yoo, Kwang-Ha (Department of Internal Medicine, Konkuk University College of Medicine) ;
  • Park, Hye-Yoon (Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Lee, Jae-Seung (Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Huh, Jin-Won (Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Oh, Yeon-Mok (Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Lim, Seong-Yong (Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Jung, Ji-Ye (Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Kim, Young-Sam (Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Kim, Hui-Jung (Department of Internal Medicine, Wonkwang University Sanbon Hospital, Wonkwang University College of Medicine) ;
  • Rhee, Chin-Kook (Department of Internal Medicine, Seoul St. Mary's Hospital) ;
  • Kim, Young-Kyoon (Department of Internal Medicine, Seoul St. Mary's Hospital) ;
  • Kim, Jin-Woo (Department of Internal Medicine, Uijeongbu St. Mary's Hospital) ;
  • Yoon, Hyoung-Kyu (Department of Internal Medicine, Yeouido St. Mary's Hospital, The Catholic University of Korea College of Medicine) ;
  • Lee, Sang-Do (Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine)
  • 이세원 (서울대학교 의과대학 분당서울대학교병원 내과학교실) ;
  • 유지홍 (경희대병원 내과) ;
  • 박명재 (경희대병원 내과) ;
  • 김은경 (차의과대학교 분당차병원 내과) ;
  • 윤호일 (서울대학교 의과대학 분당서울대학교병원 내과학교실) ;
  • 김덕겸 (서울대학교 의과대학 서울시립보라매병원 내과학교실) ;
  • 이창훈 (서울대학교 의과대학 서울시립보라매병원 내과학교실) ;
  • 박용범 (한림대학교 의과대학 강동성심병원 내과학교실) ;
  • 박주헌 (아주대학교 의과대학 호흡기내과학교실) ;
  • 황용일 (한림대학교 성심병원 내과) ;
  • 정기석 (한림대학교 성심병원 내과) ;
  • 유광하 (건국대학교 의과대학 내과학교실) ;
  • 박혜윤 (성균관대학교 의과대학 삼성서울병원 내과학교실) ;
  • 이재승 (울산대학교 의과대학 서울아산병원 내과학교실) ;
  • 허진원 (울산대학교 의과대학 서울아산병원 내과학교실) ;
  • 오연목 (울산대학교 의과대학 서울아산병원 내과학교실) ;
  • 임성용 (성균관대학교 의과대학 내과학교실 강북삼성병원 호흡기내과) ;
  • 정지예 (연세대학교 의과대학 내과학교실) ;
  • 김영삼 (연세대학교 의과대학 내과학교실) ;
  • 김휘정 (원광대학교 의과대학 산본병원 내과학교실) ;
  • 이진국 (가톨릭대학교 의과대학 서울성모병원 내과학교실) ;
  • 김영균 (가톨릭대학교 의과대학 서울성모병원 내과학교실) ;
  • 김진우 (가톨릭대학교 의과대학 의정부성모병원 내과학교실) ;
  • 윤형규 (가톨릭대학교 의과대학 여의도성모병원 내과학교실) ;
  • 이상도 (울산대학교 의과대학 서울아산병원 내과학교실)
  • Received : 2011.02.11
  • Accepted : 2011.04.13
  • Published : 2011.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Chronic obstructive pulmonary disease (COPD) is a substantially under-diagnosed disorder, and the diagnosis is usually delayed until the disease is advanced. However, the benefit of early diagnosis is not yet clear, and there are no guidelines in Korea for doing early diagnosis. This review highlights several issues regarding early diagnosis of COPD. On the basis of several lines of evidence, early diagnosis seems quite necessary and beneficial to patients. Early diagnosis can be approached by several methods, but it should be confirmed by quality-controlled spirometry. Compared with its potential benefit, the adverse effects of spirometry or pharmacotherapy appear relatively small. Although it is difficult to evaluate the benefit of early diagnosis by well-designed trials, several lines of evidence suggest that we should try to diagnose and manage patients with COPD at early stages of the disease.

Keywords

References

  1. Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006;27:397-412. https://doi.org/10.1183/09031936.06.00025805
  2. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442. https://doi.org/10.1371/journal.pmed.0030442
  3. Kim DS, Kim YS, Jung KS, Chang JH, Lim CM, Lee JH, et al. Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey. Am J Respir Crit Care Med 2005;172:842-7. https://doi.org/10.1164/rccm.200502-259OC
  4. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2008). Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute; 2008.
  5. Menezes AM, Perez-Padilla R, Jardim JR, Muino A, Lopez MV, Valdivia G, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005;366: 1875-81. https://doi.org/10.1016/S0140-6736(05)67632-5
  6. Pena VS, Miravitlles M, Gabriel R, Jimenez-Ruiz CA, Villasante C, Masa JF, et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest 2000;118:981-9. https://doi.org/10.1378/chest.118.4.981
  7. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007;370: 765-73. https://doi.org/10.1016/S0140-6736(07)61380-4
  8. Ofir D, Laveneziana P, Webb KA, Lam YM, O'Donnell DE. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008;177:622-9. https://doi.org/10.1164/rccm.200707-1064OC
  9. Ferrer M, Alonso J, Morera J, Marrades RM, Khalaf A, Aguar MC, et al. Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group. Ann Intern Med 1997;127:1072-9. https://doi.org/10.7326/0003-4819-127-12-199712150-00003
  10. Mannino DM, Doherty DE, Sonia Buist A. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med 2006;100:115-22. https://doi.org/10.1016/j.rmed.2005.03.035
  11. Troosters T, Sciurba F, Battaglia S, Langer D, Valluri SR, Martino L, et al. Physical inactivity in patients with COPD, a controlled multi-center pilot-study. Respir Med 2010;104:1005-11. https://doi.org/10.1016/j.rmed.2010.01.012
  12. Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010;363:1128-38. https://doi.org/10.1056/NEJMoa0909883
  13. Rennard S, Decramer M, Calverley PM, Pride NB, Soriano JB, Vermeire PA, et al. Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J 2002;20:799-805. https://doi.org/10.1183/09031936.02.03242002
  14. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176:532-55. https://doi.org/10.1164/rccm.200703-456SO
  15. Qaseem A, Snow V, Shekelle P, Sherif K, Wilt TJ, Weinberger S, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2007;147:633-8. https://doi.org/10.7326/0003-4819-147-9-200711060-00008
  16. Lin K, Watkins B, Johnson T, Rodriguez JA, Barton MB; U.S. Preventive Services Task Force. Screening for chronic obstructive pulmonary disease using spirometry: summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2008;148: 535-43. https://doi.org/10.7326/0003-4819-148-7-200804010-00213
  17. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet 2009;374:733-43. https://doi.org/10.1016/S0140-6736(09)61303-9
  18. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000;160:1683-9. https://doi.org/10.1001/archinte.160.11.1683
  19. Badgett RG, Tanaka DJ, Hunt DK, Jelley MJ, Feinberg LE, Steiner JF, et al. Can moderate chronic obstructive pulmonary disease be diagnosed by historical and physical findings alone? Am J Med 1993;94:188-96. https://doi.org/10.1016/0002-9343(93)90182-O
  20. Mannino DM, Etzel RA, Flanders WD. Do the medical history and physical examination predict low lung function? Arch Intern Med 1993;153:1892-7. https://doi.org/10.1001/archinte.1993.00410160052004
  21. American Thoracic Society; European Respiratory Society Task Force. Standards for the diagnosis and management of patients with COPD [Internet]. Version 1.2. New York: American Thoracic Society; 2004 [updated 2005 September 8]. [cited 2010 Nov 8]. Available from: http://www.thoracic.org/go/copd.
  22. Johannessen A, Lehmann S, Omenaas ER, Eide GE, Bakke PS, Gulsvik A. Post-bronchodilator spirometry reference values in adults and implications for disease management. Am J Respir Crit Care Med 2006;173: 1316-25. https://doi.org/10.1164/rccm.200601-023OC
  23. Swanney MP, Ruppel G, Enright PL, Pedersen OF, Crapo RO, Miller MR, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax 2008;63:1046-51. https://doi.org/10.1136/thx.2008.098483
  24. Choi JK, Paek D, Lee JO. Normal predictive values of spirometry in Korean population. Tuberc Respir Dis 2005;58:230-42.
  25. Parkes G, Greenhalgh T, Griffin M, Dent R. Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial. BMJ 2008;336: 598-600. https://doi.org/10.1136/bmj.39503.582396.25
  26. Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007;356:775-89. https://doi.org/10.1056/NEJMoa063070
  27. Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008; 359:1543-54. https://doi.org/10.1056/NEJMoa0805800
  28. Jenkins CR, Jones PW, Calverley PM, Celli B, Anderson JA, Ferguson GT, et al. Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo- controlled TORCH study. Respir Res 2009;10:59. https://doi.org/10.1186/1465-9921-10-59
  29. Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP, et al. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet 2009;374: 1171-8. https://doi.org/10.1016/S0140-6736(09)61298-8
  30. Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994;331:778-84. https://doi.org/10.1056/NEJM199409223311206
  31. Jackson LA, Neuzil KM, Yu O, Benson P, Barlow WE, Adams AL, et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med 2003;348:1747-55. https://doi.org/10.1056/NEJMoa022678
  32. Nichol KL, Baken L, Wuorenma J, Nelson A. The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease. Arch Intern Med 1999;159:2437-42. https://doi.org/10.1001/archinte.159.20.2437
  33. Alfageme I, Vazquez R, Reyes N, Munoz J, Fernandez A, Hernandez M, et al. Clinical efficacy of anti-pneumococcal vaccination in patients with COPD. Thorax 2006;61:189-95. https://doi.org/10.1136/thx.2005.043323
  34. Fields CL, Byrd RP Jr, Ossorio MA, Roy TM, Michaels MJ, Vogel RL. Cardiac arrhythmias during performance of the flow-volume loop. Chest 1993;103:1006-9. https://doi.org/10.1378/chest.103.4.1006
  35. Hardie JA, Buist AS, Vollmer WM, Ellingsen I, Bakke PS, Morkve O. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 2002;20:1117-22. https://doi.org/10.1183/09031936.02.00023202
  36. Vedal S, Crapo RO. False positive rates of multiple pulmonary function tests in healthy subjects. Bull Eur Physiopathol Respir 1983;19:263-6.
  37. Strassels SA, Smith DH, Sullivan SD, Mahajan PS. The costs of treating COPD in the United States. Chest 2001;119:344-52. https://doi.org/10.1378/chest.119.2.344
  38. van den Boom G, van Schayck CP, van Mollen MP, Tirimanna PR, den Otter JJ, van Grunsven PM, et al. Active detection of chronic obstructive pulmonary disease and asthma in the general population. Results and economic consequences of the DIMCA program. Am J Respir Crit Care Med 1998;158:1730-8. https://doi.org/10.1164/ajrccm.158.6.9709003
  39. Feenstra TL, van Genugten ML, Hoogenveen RT, Wouters EF, Rutten-van Molken MP. The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands. Am J Respir Crit Care Med 2001;164:590-6. https://doi.org/10.1164/ajrccm.164.4.2003167
  40. Dal Negro R. Optimizing economic outcomes in the management of COPD. Int J Chron Obstruct Pulmon Dis 2008;3:1-10. https://doi.org/10.2147/COPD.S671

Cited by

  1. Prevalence of Chronic Obstructive Pulmonary Disease in Korea: The Result of Forth Korean National Health and Nutrition Examination Survey vol.71, pp.5, 2011, https://doi.org/10.4046/trd.2011.71.5.328
  2. 만성폐쇄성폐질환 유소견 성인의 폐쇄성 기류제한 상태 비인지 영향요인 vol.29, pp.3, 2018, https://doi.org/10.12799/jkachn.2018.29.3.290
  3. Asthma-COPD Overlap (ACO) among Adult-onset Asthma Patients vol.16, pp.None, 2011, https://doi.org/10.2174/1573398x16999200629002849